CTOs on the Move

Cvrx

www.cvrx.com

 
CVRx® is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is supported by an outstanding board of directors and a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure. CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure. This new device called Barostim ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.cvrx.com
  • 9201 W Broadway Ave Ste 650
    Minneapolis, MN USA 55445
  • Phone: 763.416.2840

Executives

Name Title Contact Details
Rick Mueller
 Director of Information Technology Profile

Funding

Cvrx raised $93M on 08/09/2016
Cvrx raised $93M on 06/03/2019
Cvrx raised $50M on 07/07/2020

Similar Companies

Biowatch Medical Inc (Main)

Biowatch Medical Inc (Main) is a Columbia, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biosound Esaote Inc

Biosound Esaote Inc is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

iCAD

With iCAD`s technology, cancer has finally met its match. As a global medical technology leader providing innovative cancer detection and therapy solutions, our technologies empower clinicians worldwide with an arsenal of tools to detect cancer and stop it in its tracks – streamlining workflow, improving accuracy, and personalizing results like never before. The ProFound AI Breast Health Suite is the first, best, and only complete, triple-threat solution that combines cancer detection, density assessment, and risk evaluation – all designed to accelerate discovery and improve outcomes. Our leading-edge cancer detection solution, ProFound AI®, is clinically proven to find cancers earlier and with greater accuracy, while slashing reading time for radiologists by more than half. PowerLook® Density Assessment simplifies and standardizes breast density reporting and stratification, offering consistent, accurate and reliable breast density categorization. And the latest addition to our Breast AI Suite, ProFound AI® Risk, is the world`s first clinical decision support tool that provides an accurate short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram. Our Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is transforming the cancer treatment experience by empowering physicians to precisely and effectively target tumors anywhere in the body, anywhere in the world. Using the world`s smallest X-ray source, clinicians can precisely destroy disease while preserving healthy tissue, leaving cancer nowhere to hide.

Medical Informatics Engineering

Founded in 1995, MIE has developed the WebChart EHR portfolio, a minimally invasive EHR which operates on any web browser or mobile device, including iPads or Smartphones.

Cannuflow

Cannuflow Incorporated is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.